Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)

ClinicalTrials.gov ID: NCT04929483

Public ClinicalTrials.gov record NCT04929483. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 4:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of BIO89-100 in Subjects With Biopsy-Confirmed Nonalcoholic Steatohepatitis (NASH)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, placebo-controlled study that will evaluate the safety, efficacy, tolerability of BIO89-100 in patients with biopsy-confirmed fibrosis stages F2-F3 NASH.

Study identification

NCT ID
NCT04929483
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
89bio, Inc.
Industry
Enrollment
222 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
21 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 3, 2021
Primary completion
Feb 13, 2023
Completion
Oct 7, 2024
Last update posted
Jan 5, 2026

2021 – 2024

United States locations

U.S. sites
88
U.S. states
24
U.S. cities
71
Facility City State ZIP Site status
89bio Clinical Study Site Birmingham Alabama 35209
89bio Clinical Study Site Birmingham Alabama 35211
89bio Clinical Study Site Dothan Alabama 36305
89bio Clinical Study Site Guntersville Alabama 35976
89bio Clinical Study Site Madison Alabama 35758
89bio Clinical Study Site Chandler Arizona 85224
89bio Clinical Study Site Glendale Arizona 85036
89bio Clinical Study Site Peoria Arizona 85306
89bio Clinical Study Site Tucson Arizona 85712-4044
89bio Clinical Study Site Tucson Arizona 85712-4046
89bio Clinical Study Site Tucson Arizona 85741
89bio Clinical Study Site Little Rock Arkansas 72205-6414
89bio Clinical Study Site Little Rock Arkansas 72205
89bio Clinical Study Site Chula Vista California 91911
89bio Clinical Study Site Huntington Park California 90255
89bio Clinical Study Site Long Beach California 90808
89bio Clinical Study Site Orange California 92866
89bio Clinical Study Site Panorama City California 91402
89bio Clinical Study Site Rialto California 92377
89bio Clinical Study Site Santa Ana California 92704
89bio Clinical Study Site Englewood Colorado 80113
89bio Clinical Study Site Boynton Beach Florida 33472
89bio Clinical Study Site Bradenton Florida 34208
89bio Clinical Study Site Fort Myers Florida 33912
89bio Clinical Study Site Lakeland Florida 33805
89bio Clinical Study Site Maitland Florida 32127
89bio Clinical Study Site Miami Florida 33014
89bio Clinical Study Site Miami Florida 33147
89bio Clinical Study Site Miami Florida 33157
89bio Clinical Study Site Miami Lakes Florida 33016
89bio Clinical Study Site Ocala Florida 34471
89bio Clinical Study Site Palmetto Bay Florida 33157
89bio Clinical Study Site Pinellas Park Florida 33781
89bio Clinical Study Site Port Orange Florida 32127
89bio Clinical Study Site Sarasota Florida 34240
89bio Clinical Study Site Viera Florida 32940
89bio Clinical Study Site Athens Georgia 30607
89bio Clinical Study Site Sandy Springs Georgia 30328
89bio Clinical Study Site New Albany Indiana 47150
89bio Clinical Study Site South Bend Indiana 46635
89bio Clinical Study Site Iowa City Iowa 52246
89bio Clinical Study Site Topeka Kansas 66606
89bio Clinical Study Site Marrero Louisiana 70072-3151
89bio Clinical Study Site Marrero Louisiana 70072-3155
89bio Clinical Study Site Monroe Louisiana 71201
89bio Clinical Study Site Shreveport Louisiana 71103
89bio Clinical Study Site Glen Burnie Maryland 21061
89bio Clinical Study Site Greenbelt Maryland 20770
89bio Clinical Study Site St Louis Missouri 63033
89bio Clinical Study Site Las Vegas Nevada 89119
89bio Clinical Study Site Las Vegas Nevada 89121
89bio Clinical Study Site Florham Park New Jersey 07932
89bio Clinical Study Site New York New York 10033
89bio Clinical Study Site Concord North Carolina 28027
89bio Clinical Study Site Columbus Ohio 43210
89bio Clinical Study Site Dayton Ohio 45414
89bio Clinical Study Site Springboro Ohio 45066
89bio Clinical Study Site Westlake Ohio 44145
89bio Clinical Study Site Greenwood South Carolina 29646
89bio Clinical Study Site Summerville South Carolina 29485
89bio Clinical Study Site Chattanooga Tennessee 37411
89bio Clinical Study Site Chattanooga Tennessee 37421
89bio Clinical Study Site Hermitage Tennessee 37076
89bio Clinical Study Site Austin Texas 78757-8051
89bio Clinical Study Site Austin Texas 78757-8059
89bio Clinical Study Site Beaumont Texas 77702
89bio Clinical Study Site Dallas Texas 75234
89bio Clinical Study Site Dallas Texas 75246
89bio Clinical Study Site Edinburg Texas 78539
89bio Clinical Study Site Fort Worth Texas 76104
89bio Clinical Study Site Garland Texas 75044
89bio Clinical Study Site Houston Texas 77030
89bio Clinical Study Site Houston Texas 77099
89bio Clinical Study Site San Antonio Texas 78209
89bio Clinical Study Site San Antonio Texas 78215
89bio Clinical Study Site San Antonio Texas 78229-4801
89bio Clinical Study Site San Antonio Texas 78229-5069
89bio Clinical Study Site Waco Texas 76710
89bio Clinical Study Site Waco Texas 76712
89bio Clinical Study Site Wichita Falls Texas 76301
89bio Clinical Study Site Ogden Utah 84405
89bio Clinical Study Site Sandy City Utah 84092
89bio Clinical Study Site Manassas Virginia 20110
89bio Clinical Study Site Richmond Virginia 23235
89bio Clinical Study Site Richmond Virginia 23249
89bio Clinical Study Site Roanoke Virginia 24014
89bio Clinical Study Site Seattle Washington 98105
89bio Clinical Study Site Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04929483, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 5, 2026 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04929483 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →